Page 145 - Read Online
P. 145

Wallace et al. J Cancer Metastasis Treat 2019;5:9  I  http://dx.doi.org/10.20517/2394-4722.2019.01                        Page 17 of 18

               122.  Naci D, Vuori K, Aoudjit F. Alpha2beta1 integrin in cancer development and chemoresistance. Semin Cancer Biol 2015;35:145-53.
               123.  Broom OJ, Massoumi R, Sjolander A. Alpha2beta1 integrin signalling enhances cyclooxygenase-2 expression in intestinal epithelial cells. J
                   Cell Physiol 2006;209:950-8.
               124.  Esquivel-Velazquez M, Ostoa-Saloma P, Palacios-Arreola MI, Nava-Castro KE, Castro JI, et al. The role of cytokines in breast cancer
                   development and progression. J Interferon Cytokine Res 2015;35:1-16.
               125.  Vannini F, Kashfi K, Nath N. The dual role of iNOS in cancer. Redox Biol 2015;6:334-43.
               126.  Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep 2014;6:13.
               127.  Chen Y, Zhang S, Wang Q, Zhang X. Tumor-recruited M2 macrophages promote gastric and breast cancer metastasis via M2 macrophage-
                   secreted CHI3L1 protein. J Hematol Oncol 2017;10:36.
               128.  Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell 2010;141:39-51.
               129.  Vasiliadou I, Holen I. The role of macrophages in bone metastasis. J Bone Oncol 2013;2:158-66.
               130.  Wyckoff JB, Wang Y, Lin EY, Li JF, Goswami S, et al. Direct visualization of macrophage-assisted tumor cell intravasation in mammary
                   tumors. Cancer Res 2007;67:2649-56.
               131.  Lin EY, Nguyen AV, Russell RG, Pollard JW. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp
                   Med 2001;193:727-40.
               132.  Monks J, Rosner D, Geske FJ, Lehman L, Hanson L, et al. Epithelial cells as phagocytes: apoptotic epithelial cells are engulfed by
                   mammary alveolar epithelial cells and repress inflammatory mediator release. Cell Death Differ 2005;12:107-14.
               133.  Monks J, Smith-Steinhart C, Kruk ER, Fadok VA, Henson PM. Epithelial cells remove apoptotic epithelial cells during post-lactation
                   involution of the mouse mammary gland. Biol Reprod 2008;78:586-94.
               134.  O’Brien J, Martinson H, Durand-Rougely C, Schedin P. Macrophages are crucial for epithelial cell death and adipocyte repopulation during
                   mammary gland involution. Development 2012;139:269-75.
               135.  Harney AS, Arwert EN, Entenberg D, Wang Y, Guo P, et al. Real-time imaging reveals local, transient vascular permeability, and tumor cell
                   intravasation stimulated by TIE2hi macrophage-derived VEGFA. Cancer Discov 2015;5:932-43.
               136.  Holmes S, Downs AM, Fosberry A, Hayes PD, Michalovich D, et al. Sema7A is a potent monocyte stimulator. Scand J Immunol
                   2002;56:270-5.
               137.  Hugo HJ, Saunders C, Ramsay RG, Thompson EW. New insights on COX-2 in chronic inflammation driving breast cancer growth and
                   metastasis. J Mammary Gland Biol Neoplasia 2015;20:109-19.
               138.  Gan L, Qiu Z, Huang J, Li Y, Huang H, et al. Cyclooxygenase-2 in tumor-associated macrophages promotes metastatic potential of breast
                   cancer cells through Akt pathway. Int J Biol Sci 2016;12:1533-43.
               139.  Esbona K, Yi Y, Saha S, Yu M, Van Doorn RR, et al. The presence of cyclooxygenase 2, tumor-associated macrophages, and collagen
                   alignment as prognostic markers for invasive breast carcinoma patients. Am J Pathol 2018;188:559-73.
               140.  Ingman WV, Wyckoff J, Gouon-Evans V, Condeelis J, Pollard JW. Macrophages promote collagen fibrillogenesis around terminal end buds
                   of the developing mammary gland. Dev Dyn 2006;235:3222-9.
               141.  Muthukkaruppan VR, Kubai L, Auerbach R. Tumor-induced neovascularization in the mouse eye. J Natl Cancer Inst 1982;69:699-708.
               142.  Holmgren L, O’Reilly MS, Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis
                   suppression. Nat Med 1995;1:149-53.
               143.  Parangi S, O’Reilly M, Christofori G, Holmgren L, Grosfeld J, et al. Antiangiogenic therapy of transgenic mice impairs de novo tumor
                   growth. Proc Natl Acad Sci U S A 1996;93:2002-7.
               144.  Ramirez RA, Lee A, Schedin P, Russell JS, Masso-Welch PA. Alterations in mast cell frequency and relationship to angiogenesis in the rat
                   mammary gland during windows of physiologic tissue remodeling. Dev Dyn 2012;241:890-900.
               145.  Pepper MS, Baetens D, Mandriota SJ, Di Sanza C, Oikemus S, et al. Regulation of VEGF and VEGF receptor expression in the rodent
                   mammary gland during pregnancy, lactation, and involution. Dev Dyn 2000;218:507-24.
               146.  Chan TR, Stahl PJ, Li Y, Yu SM. Collagen-gelatin mixtures as wound model, and substrates for VEGF-mimetic peptide binding and
                   endothelial cell activation. Acta Biomater 2015;15:164-72.
               147.  Bordeleau F, Mason BN, Lollis EM, Mazzola M, Zanotelli MR, et al. Matrix stiffening promotes a tumor vasculature phenotype. Proc Natl
                   Acad Sci U S A 2017;114:492-7.
               148.  Samani A, Zubovits J, Plewes D. Elastic moduli of normal and pathological human breast tissues: an inversion-technique-based
                   investigation of 169 samples. Phys Med Biol 2007;52:1565-76.
               149.  Fang M, Yuan J, Peng C, Li Y. Collagen as a double-edged sword in tumor progression. Tumour Biol 2014;35:2871-82.
               150.  Masson N, Ratcliffe PJ. HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O(2) levels. J Cell Sci
                   2003;116:3041-9.
               151.  Takeda N, Maemura K, Imai Y, Harada T, Kawanami D, et al. Endothelial PAS domain protein 1 gene promotes angiogenesis through the
                   transactivation of both vascular endothelial growth factor and its receptor, Flt-1. Circ Res 2004;95:146-53.
               152.  Kaidi A, Qualtrough D, Williams AC, Paraskeva C. Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor
                   (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia. Cancer Res 2006;66:6683-91.
               153.  Greenhough A, Smartt HJ, Moore AE, Roberts HR, Williams AC, et al. The COX-2/PGE2 pathway: key roles in the hallmarks of cancer
                   and adaptation to the tumour microenvironment. Carcinogenesis 2009;30:377-86.
               154.  Jones MK, Wang H, Peskar BM, Levin E, Itani RM, et al. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into
                   mechanisms and implications for cancer growth and ulcer healing. Nat Med 1999;5:1418-23.
               155.  Morote-Garcia JC, Napiwotzky D, Kohler D, Rosenberger P. Endothelial semaphorin 7A promotes neutrophil migration during hypoxia.
                   Proc Natl Acad Sci U S A 2012;109:14146-51.
               156.  Zhang M, Wang L, Dong M, Li Z, Jin F. Endothelial semaphorin 7A promotes inflammation in seawater aspiration-induced acute lung
                   injury. Int J Mol Sci 2014;15:19650-61.
   140   141   142   143   144   145   146   147   148   149   150